188 related articles for article (PubMed ID: 27081461)
1. Effect of coating thickness of iron oxide nanoparticles on their relaxivity in the MRI.
Hajesmaeelzadeh F; Shanehsazzadeh S; Grüttner C; Daha FJ; Oghabian MA
Iran J Basic Med Sci; 2016 Feb; 19(2):166-71. PubMed ID: 27081461
[TBL] [Abstract][Full Text] [Related]
2. Coating thickness of magnetic iron oxide nanoparticles affects R2 relaxivity.
LaConte LE; Nitin N; Zurkiya O; Caruntu D; O'Connor CJ; Hu X; Bao G
J Magn Reson Imaging; 2007 Dec; 26(6):1634-41. PubMed ID: 17968941
[TBL] [Abstract][Full Text] [Related]
3. Studying the effect of particle size and coating type on the blood kinetics of superparamagnetic iron oxide nanoparticles.
Roohi F; Lohrke J; Ide A; Schütz G; Dassler K
Int J Nanomedicine; 2012; 7():4447-58. PubMed ID: 22927759
[TBL] [Abstract][Full Text] [Related]
4. Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis.
Saraswathy A; Nazeer SS; Jeevan M; Nimi N; Arumugam S; Harikrishnan VS; Varma PR; Jayasree RS
Colloids Surf B Biointerfaces; 2014 May; 117():216-24. PubMed ID: 24646453
[TBL] [Abstract][Full Text] [Related]
5. Short-chain PEG molecules strongly bound to magnetic nanoparticle for MRI long circulating agents.
Ruiz A; Salas G; Calero M; Hernández Y; Villanueva A; Herranz F; Veintemillas-Verdaguer S; Martínez E; Barber DF; Morales MP
Acta Biomater; 2013 May; 9(5):6421-30. PubMed ID: 23321305
[TBL] [Abstract][Full Text] [Related]
6. Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent.
Deng LH; Jiang H; Lu FL; Wang HW; Pu Y; Wu CQ; Tang HJ; Xu Y; Chen TW; Zhu J; Shen CY; Zhang XM
Int J Nanomedicine; 2021; 16():201-211. PubMed ID: 33447035
[TBL] [Abstract][Full Text] [Related]
7. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
[TBL] [Abstract][Full Text] [Related]
8. PEG coating reduces NMR relaxivity of Mn(0.5)Zn(0.5)Gd(0.02)Fe(1.98)O4 hyperthermia nanoparticles.
Issa B; Qadri S; Obaidat IM; Bowtell RW; Haik Y
J Magn Reson Imaging; 2011 Nov; 34(5):1192-8. PubMed ID: 21928382
[TBL] [Abstract][Full Text] [Related]
9. Casein-Coated Fe5C2 Nanoparticles with Superior r2 Relaxivity for Liver-Specific Magnetic Resonance Imaging.
Cowger TA; Tang W; Zhen Z; Hu K; Rink DE; Todd TJ; Wang GD; Zhang W; Chen H; Xie J
Theranostics; 2015; 5(11):1225-32. PubMed ID: 26379788
[TBL] [Abstract][Full Text] [Related]
10. [Preparation and characterization of superparamagnetic iron oxide nanoparticles].
Liu ST; Yan Y; Chen ZL; Zhang YZ; Jin X
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):331-4. PubMed ID: 16546740
[TBL] [Abstract][Full Text] [Related]
11. Application of magnetic iron oxide nanoparticles: Thrombotic activity, imaging and cytocompatibility of silica-coated and carboxymethyl dextrane-coated particles.
Turrina C; Schoenen M; Milani D; Klassen A; Rojas Gonzaléz DM; Cvirn G; Mela P; Berensmeier S; Slabu I; Schwaminger SP
Colloids Surf B Biointerfaces; 2023 Aug; 228():113428. PubMed ID: 37379701
[TBL] [Abstract][Full Text] [Related]
12. Coating optimization of superparamagnetic iron oxide nanoparticles for high T2 relaxivity.
Tong S; Hou S; Zheng Z; Zhou J; Bao G
Nano Lett; 2010 Nov; 10(11):4607-13. PubMed ID: 20939602
[TBL] [Abstract][Full Text] [Related]
13. One-pot facile synthesis of PEGylated superparamagnetic iron oxide nanoparticles for MRI contrast enhancement.
Dai L; Liu Y; Wang Z; Guo F; Shi D; Zhang B
Mater Sci Eng C Mater Biol Appl; 2014 Aug; 41():161-7. PubMed ID: 24907749
[TBL] [Abstract][Full Text] [Related]
14. Engineered magnetic hybrid nanoparticles with enhanced relaxivity for tumor imaging.
Aryal S; Key J; Stigliano C; Ananta JS; Zhong M; Decuzzi P
Biomaterials; 2013 Oct; 34(31):7725-32. PubMed ID: 23871540
[TBL] [Abstract][Full Text] [Related]
15. Characterization of ultrasmall magnetite [correction of paramagnetic magnetite] particles as superparamagnetic contrast agents in MRI.
Grimm J; Karger N; Lüsse S; Winoto-Morbach S; Krisch B; Müller-Hülsbeck S; Heller M
Invest Radiol; 2000 Sep; 35(9):553-6. PubMed ID: 10982000
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
